Gold’s Epic Rally Ends With a Shock Slump: What’s Next for Bullion?
4 November 2025
3 mins read

Gold Just Slipped Under $4,000—Then Bounced: Can Bulls Save 2025’s Record Run? (Nov 4, 2025)

Key facts (Nov 4, 2025):

  • Spot gold dipped as low as $3,970/oz early Tuesday, then pared losses to around $3,994/oz at 12:10 GMTDec COMEX futures hovered near $4,005/ozReuters
  • Drivers today: a pause in the dollar’s rally and slightly softer 10‑year U.S. yields helped stabilize prices after an early slide below $4,000.  Reuters
  • Other metals: silver ~$47.80/ozplatinum ~$1,558/ozpalladium ~$1,405/oz (midday GMT).  Reuters
  • Equities tied to gold: GLD last $368.78GDX about $71.30, and Newmont (NEM) near $81.62 (prices delayed; intraday ranges narrow).  Reuters
  • Macro context: The Fed cut rates last week for the 2nd time in 2025 but signaled no guarantee of another cut; markets now see ~65% odds for December.  Reuters
  • Positioning backdrop: Q3 gold demand hit a quarterly record, with central banks buying ~220t (+10% y/y)and ETF inflows surging, per WGC.  Reuters

What happened today

Gold started the session on the back foot—slipping below $4,000/oz as the dollar extended last week’s strength—then recovered most losses by midday as the greenback cooled and U.S. yields eased. At 06:25 GMT, spot was ~$3,970, but by 12:10 GMT prices had improved to ~$3,994December futures were near $4,004.70Reuters

The intraday swing reflects the push‑pull of currency and rates: Reuters noted the dollar index eased after a three‑month high, while 10‑year Treasury yields drifted off Monday’s peak—both supportive for non‑yielding gold.  Reuters

What the pros are saying

Gold is consolidating in the region of $4,000,” said Carlo Alberto De Casa of Swissquote, adding the next few weeks will help determine whether the market resumes its rally or corrects.  Reuters

Fawad Razaqzada of City Index/FOREX.com noted that the “initial break below [$4,000] triggered a wave of technical selling and unwinding of long positions.”  Reuters

Cross‑asset check

  • Dollar & yields: The USD rally paused today after recent highs; benchmark 10‑year yields eased versus Monday. (For reference, external trackers show the 10‑year around ~4.1% today.)  Reuters
  • Risk sentiment: Related coverage shows risk assets wobbly as traders reassess the odds of another 2025 Fed cut.  Reuters

Stocks & ETFs linked to gold (as of publication; delayed quotes)

  • SPDR Gold Shares (GLD): $368.78; 52‑week $236.13–$403.30Reuters
  • VanEck Gold Miners (GDX): ~$71.30 (−~1.0% intraday).  Reuters
  • Newmont (NEM): ~$81.62Reuters

Prices are indicative and may update; check your broker for live quotes.

Big‑picture backdrop: still supportive, but choppy

  • Policy: The Fed’s second cut of 2025 is in the rearview, and Chair Powell stressed another move this year is “not a foregone conclusion.” Markets put ~65% odds on a December cut—less bullish than a week ago—leaving gold sensitive to incoming data (ADP, ISM).  Reuters
  • Demand: The World Gold Council says Q3 demand hit a record 1,313t, powered by ETF inflows and bar/coin buyingcentral bank purchases climbed to ~220t (+10% y/y). That structural bid has helped cushion pullbacks.  Reuters

Forecasts & scenarios

  • Banks’ targets:
    • Morgan Stanley sees potential for $4,500/oz by mid‑2026, citing ETF and central‑bank demand as rates drift lower.  Reuters
    • ANZ (Sept) lifted its 2025 year‑end target to $3,800, peaking near $4,000 by mid‑2026 on robust investment demand and official‑sector buying.  Reuters
    • Goldman Sachs has discussed upside toward ~$5,000 under a stress scenario where perceived threats to Fed independence spark bigger private shifts into gold; base‑case eyes $4,000 by mid‑2026Reuters

Our read (near‑term):

  • Base case (next 1–2 weeks): Range‑trade around $3,950–$4,050 as markets digest jobs and PMI data and December Fed odds oscillate. A firm USD/up‑yields combo argues for choppy consolidationReuters
  • Bull case: A softer dollar and cooler data revive cut hopes, inviting tests of $4,080–$4,150 (recent resistance zone).  Reuters
  • Bear case: A decisive USD breakout or rates re‑acceleration risks a push toward $3,900 and, if momentum builds, $3,700–$3,800 support flagged by recent sell‑side chatter.  Financial Times

Levels to watch

  • Support: $3,950 (round‑number/spot shelf), then $3,900; deeper support $3,700–$3,800 if risk‑off turns into position clean‑up.  Reuters
  • Resistance: $4,050–$4,100, then $4,150+ (area of mid‑October highs).  Reuters

Today’s related headlines (Nov 4)

  • Gold trims losses as dollar rally pauses; eyes U.S. data.  Reuters
  • Rand weakens as gold slips below $4,000 earlier in session.  Reuters
  • Dollar narrative: rally cooled today after touching a three‑month high on Monday.  Reuters

Data notes & sources

Spot and futures prices, expert quotes, and macro context are from Reuters intraday market reports on Nov 4, 2025; additional spot snapshots and yields from TradingEconomics and WGC provide corroboration on levels and demand trends; ETF and miner quotes are from Reuters quote pages (delayed).  Reuters

This article is for general information only and is not investment advice.

Stock Market Today

  • Trevi Therapeutics (TRVI) valuation under scrutiny after FDA End of Phase 2 update
    January 11, 2026, 6:56 PM EST. Trevi Therapeutics (TRVI) trades near $11.18 after updating investors on an FDA End of Phase 2 meeting for its chronic cough program in idiopathic pulmonary fibrosis. The stock shows mixed momentum: 30-day return down 12.45%, 90-day gain 15.14%, and 1-year total shareholder return around 192.67%. With analyst targets in the high teens to low $20s, the question is whether the stock remains at a premium. On price-to-book (P/B), the multiple is 7.6x versus ~2.6x for the US Pharmaceuticals group and ~6.8x for peers, signaling an overvalued stance. The company has US$0 revenue and a net loss of US$45.86 million, leaving little room if trial readouts disappoint or funding tightens. Risks: clinical setbacks, tougher capital markets.
European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains
Previous Story

Wall Street on Edge: Bank Chiefs Warn 10–15% Pullback as Fed Flies Blind—Futures Slide, Big Tech Wobbles (Nov. 4, 2025)

Amazon’s $2.5 Billion Cloud Outage: How an AI Glitch Broke the Internet – Again
Next Story

Amazon’s $2.5 Billion Cloud Outage: How an AI Glitch Broke the Internet – Again

Go toTop